Presentation will be Webcast Live and Archived on Vanda's Website
WASHINGTON, June 19, 2015 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) VNDA, a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system disorders, today announced that Jim Kelly, Vanda's Senior Vice President and Chief Financial Officer, will deliver a corporate presentation at the JMP Securities Life Sciences Conference in New York City on Tuesday, June 23, 2015 at 12:30 p.m. Eastern Time.
The presentation at the JMP Securities Life Sciences Conference will be available live on Vanda's corporate website, where it also will be archived for 30 days. To access the presentation, go to Vanda's website at www.vandapharma.com and click on the Presentations tab on the Investor Relations page. Please connect to the website several minutes prior to the start of the live presentation.
About Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system disorders. For more on Vanda Pharmaceuticals Inc., please visit www.vandapharma.com.
Company Contact:
Jim Kelly
Senior Vice President and Chief Financial Officer
Vanda Pharmaceuticals Inc.
(202) 734-3428
jim.kelly@vandapharma.com
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/vanda-pharmaceuticals-to-present-at-the-jmp-securities-life-sciences-conference-300101949.html
SOURCE Vanda Pharmaceuticals Inc.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.